Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
UnitedHealth revenue cracks $200 billion mark National health insurer UnitedHealth Group on Tuesday announced that its full-year 2017 revenue cracked the $200 billion mark for the first time, while its profit nearly doubled over 2016. On top of those stellar results, the nation’s No. 1 insurer will reap an extra $1.7 billion in earnings in 2018 thanks to the Trump administration’s recent ... Read More
Healthcare companies mulling what to do with GOP tax bill benefits For-profit healthcare companies last week were buzzing about the savings they expect to reap from the Trump administration’s sweeping tax overhaul, which reduced the corporate tax rate to 21% from 35%. Details were sparse on just how much they expect to save due to the lower tax rate—although the Express Scripts CEO said the pharmacy benefit ... Read More
Panel charged with improving nation's health IT infrastructure set to meet At long last, the Health Information Technology Advisory Committee will hold its first meeting, setting in motion a key requirement of the 21st Century Cures Act. The new committee, established more than a year ago, is slated to gather on Jan. 18. Lawmakers tasked the group with advising the Office of the National Coordinator for Health ... Read More
J.P. Morgan Healthcare Conference Wrap-Up: Transformation is becoming more than just a word SAN FRANCISCO—Health systems are turning to apps, partnerships with retail stores, revamped websites and business models outside of healthcare with the hope they can keep their heads above water as they try to ride the wave of consumerism. In presentations and meetings at the J.P. Morgan Healthcare Conference last week, executives described some of the new ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Great DTC Shake-Up Patient perspectives on direct-to-consumer advertising This in-depth eyeforpharma whitepaper, which we developed with Health Perspectives Group explores the evolving role of DTC advertising with direct feedback from patient’s – including exclusive results from the recent “DTC Attitudes, Behaviours and Preferences” patient study conducted by Health Stories Project – Insights, (HSPi). Read More